Halozyme says Dutch court upholds its patent, bars Merck from making and selling Keytruda SC in multiple European markets

Halozyme says a Dutch court upheld its patent and barred Merck from making and selling Keytruda SC in multiple European markets.

Detected & updated continuously · Source: Nebula